Progesterone resistance
Clinical trials for Progesterone resistance explained in plain language.
Never miss a new study
Get alerted when new Progesterone resistance trials appear
Sign up with your email to follow new studies for Progesterone resistance, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gonadotropin-releasing hormone agonist (GnRHa) plus letrozole in obese progestin-insensitive early-stage endometrial cancer patients with conservative treatment
Recruiting nowTo investigate the efficacy of GnRHa plus letrozole in obese progestin-insensitive EEC patients.
Matched conditions: PROGESTERONE RESISTANCE
Phase 2/3 • Sponsor: Xiaojun Chen
Last updated Sep 10, 2026 16:00 UTC
-
Gonadotropin-releasing hormone agonist (GnRHa) plus letrozole in non-obese progestin-insensitive early-stage endometrial cancer and atypical hyperplasia patients with conservative treatment
Recruiting nowTo investigate the efficacy of GnRHa plus letrozole vs Diane-35 plus metformin in non-obese progestin-insensitive early-stage endometrial cancer (EEC) and atypical hyperplasia(EAH) patients asking for conservative treatment.
Matched conditions: PROGESTERONE RESISTANCE
Phase 2/3 • Sponsor: Xiaojun Chen
Last updated Sep 10, 2026 16:00 UTC